Related Experiment Video

Updated: Oct 11, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K

COVID-19 hospitalization is associated with pulmonary/diffusion abnormalities but not post-acute sequelae of COVID-19

Grace Y Lam1,2, Dean Befus1,2, Ronald W Damant1,2

  • 1Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, Edmonton, Alberta, Canada.

Journal of Internal Medicine
|December 7, 2021
PubMed

Insights

Hospitalization may worsen pulmonary issues in long COVID patients, but doesn't impact mental health or quality of life. This study clarifies hospitalization's role in long COVID complications.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Public Health

Background:

  • The long-term effects of Coronavirus disease-19 (COVID-19), known as long COVID, are a growing concern globally.
  • Identifying risk factors for long COVID is crucial for understanding and managing the condition.
  • This study investigates whether hospitalization during acute COVID-19 infection is a risk factor for developing long COVID.

Discussion:

  • Pulmonary function, including restriction and diffusion capacity, showed significant decline at 3 months post-infection in hospitalized patients.
  • However, mental health, functional status, and quality of life impairments were comparable between hospitalized and non-hospitalized individuals.
  • This suggests a nuanced relationship between hospitalization and the multifaceted nature of long COVID.

Key Insights:

  • Hospitalization is linked to increased pulmonary complications in long COVID.
  • Long COVID's impact on mental health and quality of life appears independent of acute hospitalization status.
  • The severity of overall long COVID symptoms is not solely determined by hospitalization during the initial infection.

Outlook:

  • Further research is needed to elucidate the specific mechanisms driving pulmonary long COVID.
  • Understanding these distinctions can inform targeted interventions for different patient subgroups.
  • Longitudinal studies will be essential to track the long-term trajectory of recovery and identify persistent health challenges.

Keywords:
COVID-19

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K
Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging10:44

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Published on: June 21, 2024

686

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
385
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
679
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
920
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
520
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
492
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K